The levels of CXCL10, CXCL9, and CXCL11 in the tumor correlates with the concentration of intratumoral cytotoxic lymphocytes (CTLs) and reduced tumor angiogenesis (Burkholder et al., 2014). This evidence concerns the gene CXCL10 and neoplasm.